MX2024008618A - Composiciones y métodos para el tratamiento de la depresión. - Google Patents

Composiciones y métodos para el tratamiento de la depresión.

Info

Publication number
MX2024008618A
MX2024008618A MX2024008618A MX2024008618A MX2024008618A MX 2024008618 A MX2024008618 A MX 2024008618A MX 2024008618 A MX2024008618 A MX 2024008618A MX 2024008618 A MX2024008618 A MX 2024008618A MX 2024008618 A MX2024008618 A MX 2024008618A
Authority
MX
Mexico
Prior art keywords
patient
treatment
methods
aticaprant
reuptake inhibitor
Prior art date
Application number
MX2024008618A
Other languages
English (en)
Spanish (es)
Inventor
Wayne C Drevets
Hartmuth Christian Kolb
Ziad Serhal Saad
Tina Wang
Original Assignee
Janssen Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Janssen Pharmaceuticals Inc filed Critical Janssen Pharmaceuticals Inc
Publication of MX2024008618A publication Critical patent/MX2024008618A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants

Landscapes

  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Neurology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Epidemiology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
MX2024008618A 2022-01-10 2023-01-09 Composiciones y métodos para el tratamiento de la depresión. MX2024008618A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US202263298047P 2022-01-10 2022-01-10
PCT/IB2023/050170 WO2023131920A1 (en) 2022-01-10 2023-01-09 Compositions and methods for the treatment of depression

Publications (1)

Publication Number Publication Date
MX2024008618A true MX2024008618A (es) 2024-09-25

Family

ID=84981555

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2024008618A MX2024008618A (es) 2022-01-10 2023-01-09 Composiciones y métodos para el tratamiento de la depresión.

Country Status (10)

Country Link
US (1) US20250221960A1 (https=)
EP (1) EP4463152A1 (https=)
JP (1) JP2025503646A (https=)
KR (1) KR20240132479A (https=)
CN (1) CN118510507A (https=)
AU (1) AU2023205471A1 (https=)
CA (1) CA3247760A1 (https=)
IL (1) IL314179A (https=)
MX (1) MX2024008618A (https=)
WO (1) WO2023131920A1 (https=)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2024336807A1 (en) * 2023-09-06 2026-04-16 Janssen Pharmaceuticals, Inc. Compositions comprising aticaprant for use in treating major depressive disorder

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP5345637B2 (ja) * 2008-01-22 2013-11-20 イーライ リリー アンド カンパニー κ選択的オピオイド受容体アンタゴニスト

Also Published As

Publication number Publication date
EP4463152A1 (en) 2024-11-20
CN118510507A (zh) 2024-08-16
JP2025503646A (ja) 2025-02-04
KR20240132479A (ko) 2024-09-03
WO2023131920A1 (en) 2023-07-13
IL314179A (en) 2024-09-01
CA3247760A1 (en) 2023-07-13
US20250221960A1 (en) 2025-07-10
AU2023205471A1 (en) 2024-08-29

Similar Documents

Publication Publication Date Title
CO2023015571A2 (es) Composiciones y métodos para el tratamiento de la depresión
CO2022013777A2 (es) Uso de agentes para el tratamiento de condiciones respiratorias
KR980000447A (ko) 미르타자핀과 하나 이상의 선택적인 세로토닌 재이용 저해제로 이루어진 약학 조성물
AR045710A1 (es) Uso de inhibidores de tnf alfa y composiciones farmaceuticas que los comprenden para el tratamiento a dosis bajas
CO2020008988A2 (es) Oligonucleótidos antisentido para alfa-sinucleína y usos de los mismos
AR047719A1 (es) Procedimiento para el tratamiento de trastornos de depresion y ansiedad mediante terapia de combinacion que comprenden un ligando alfa-2-delta y un ssri y/o un snri
BR112021022283A2 (pt) Novas endolisinas de gardnerella e usos das mesmas
MX2020010697A (es) Kit, composicion y terapia de combinacion para el sindrome del cromosoma x fragil.
MX2021014161A (es) Metodos de tratamiento del sindrome de sjogren utilizando un inhibidor de la tirosina quinasa de bruton.
BR9911049A (pt) Terapia combinada para tratamento de depressão resistente
MX2024008618A (es) Composiciones y métodos para el tratamiento de la depresión.
MX2025014865A (es) Metodos para tratar el cancer o enfermedad de von-hippel lindau usando una combinacion de un inhibidor de hif-2 alpha y lenvatinib
PE20240885A1 (es) Sales agonistas de sstr4
EA201992759A1 (ru) Ассоциация, включающая кислород и гиалуроновую кислоту, для местного вагинального применения
CL2022001102A1 (es) Métodos para el tratamiento de trastornos depresivos.
BRPI0916507A8 (pt) Compostos, composição cosmética, processo de tratamento cosmético não terapêutico da pele e usos não terapêuticos de uma composição cosmética
MX2024005453A (es) Composiciones y tratamientos con nirogacestat.
AR119033A1 (es) Métodos para tratar cánceres asociados con virus con inhibidores de la histona deacetilasa
DOP2023000085A (es) Regímenes para el tratamiento de los trastornos de la pérdida de cabello con inhibidores de jak deuterados
PY1944026A (es) Ácido ascórbico y compuestos quinona en combinación con un agente antiparasitario para tratar enfermedades parasitarias
CO2023017669A2 (es) Terapia combinada anti-vhc ventajosa
AR045423A1 (es) Combinaciones de analiticos y antidepresivos
BR112022010733A2 (pt) Métodos para tratar dor
AR125762A1 (es) Composiciones y métodos para el tratamiento de la depresión
MX2025005720A (es) Inhibidores de la tirosina-cinasa 2 (tyk2)